Ponatinib vs Imatinib for Ph+ ALL, Cholesterol from Childhood to Adulthood and CVD Risk, Causal Inference, and more

Release Date:

Editor’s Summary by Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for the June 4, 2024, issue.

Ponatinib vs Imatinib for Ph+ ALL, Cholesterol from Childhood to Adulthood and CVD Risk, Causal Inference, and more

Title
Corticosteroids for Duchenne Muscular Dystrophy, Pregnancy Outcomes After SARS-CoV-2 Vaccination, Association of Race and Ethnicity With Dementia, and more
Copyright
Release Date

flashback